Health Care

U.S. stocks are rising Monday morning, with health care companies making some of the largest gains after biotechnology company Gilead Sciences agreed to buy cancer drug maker Kite Pharma for $11.9 billion.

Stocks that moved substantially or traded heavily Monday: Expedia Inc., down $6.73 to $142.53

The latest on developments in financial markets (All times local): 9:35 a.m.

Gilead Sciences is buying Kite Pharma for $11.9 billion, giving the biotechnology company a broader portfolio of potential cell therapies for cancer.

Gilead Sciences has agreed to pay about $11 billion for Kite Pharma and its promising new technology for harnessing the body's immune system to fight cancer, according to people familiar with the matter.

More than 30,000 Dr. Martens boosts are being recalled because wearers can be exposed to the chemical benzidine, which is carcinogenic.

___ Walmart joins forces with Google on voice-activated shopping NEW YORK (AP) — Walmart is diving into voice-activated shopping.

The Dutch government has appointed a former justice minister to lead an investigation into the illegal use of a pesticide to treat laying hens for lice infestations, which sparked a food scare in Europe and beyond and led to the destruction of millions of eggs.

Filling a prescription is no longer the simple errand you run after a doctor visit.

Insurers face two critical deadlines in September, by which time it appears increasingly unlikely they will have clarity on a number of key issues, including whether the federal government will continue funding key ObamaCare subsidies.

Gov. Scott Walker is touting the potential that a massive Foxconn Technology Group plant could have on Wisconsin's health care industry.

AllergyKids Foundation Founder Robyn O’Brien on Tuesday said the Pharmaceutical company Mylan, should have paid more than $465 million in their settlement with the U.S. Justice Department.

A lawsuit alleges that a dangerous Takata air bag should have been recalled before going from a wrecked car to a salvage yard, eventually ending up in a 2002 Honda Accord and nearly killing a Las Vegas woman.

On Wednesday, Goldman Sachs (NYSE:GS) released its Americas Conviction List, adding biotech stock Biogen (NASDAQ:BIIB) to its list of companies with serious upside potential due to its pipeline of Alzheimer’s drugs.

The world's largest pharmaceutical manufacturer has waded into the death-penalty debate.

Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company's talc-based products like Johnson's Baby Powder for feminine hygiene.

New Hampshire will be getting $1 million from EpiPen maker Mylan as part of a national settlement.